Public market insider buying at ImmunoPrecise Antibodies (IPA)
Public market insider buying at ImmunoPrecise Antibodies (V:IPA)
Updated Wednesday Apr 06, 2022 03:36 AM EDT
Frederic Chabot, a Senior Officer, acquired 19,900 Common Shares on an indirect ownership basis for registered holder Republique Capital at prices ranging from $5.730 to $7.070 between March 30th, 2022 and April 4th, 2022. This represents a $127,349 investment into the company's shares and an account share holdings change of greater than 100%. Three other insiders were also buying.ImmunoPrecise Antibodies is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Headlines: Apr 06, 2022
IPA Insider Holdings Chart
Issuer details as of Apr 06, 2022 3:36 ET
Latest Price
7.29
1 Day Change
2.97%
52 Week High
20.2
52 Week Low
4.52
QMV ($Mils)
144,070,010
Issuer website: https://www.ipatherapeutics.com/